The BSRBR-RA study tracks the progress of people with rheumatoid arthritis (RA) who have been prescribed biologic (including biosimilar) and other targeted therapies in the UK to monitor the long-term safety of these drugs.
To find out more about the study, please visit our main site.
Latest blog posts
Another Success Story – BSRBR-RA Associate PI: Meet Ayesha
Name and role My name is Ayesha Musa and I am a Foundation Year 2 doctor. Why did you apply for the NIHR API Scheme with BSRBR-RA? I first heard of the BSRBR-RA study from my educational supervisor. It seemed like an excellent study to be involved in especially as I...
Celebrating our BSRBR-RA sites
2024 contributorsWith 600+ registrations and over 9000 follow ups completed last year, we wanted to thank our sites and acknowledge the hard work of our NHS healthcare professional colleagues. We are grateful to them for their diligence in providing the data that...
Working together in research: perspectives from researchers and patient partners
Authors: Lianne Kearsley-Fleet (researcher) and Natasha Shaw (patient partner).BackgroundResearchers are often criticised for working in isolation, looking at outcomes in people they have never even spoken to in real life. A University of Manchester researcher,...
Celebrate your registers! Development: Encouraging researchers
Research Opportunities The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BSRBR-RA) is an observational cohort study, which has collected data on over 30,000 participants in the UK over more than two decades. This extensive dataset...
Celebrate your registers! Collaboration: Successful collaboration with patient groups
The BSRBR-RA regularly collaborates with patient support groups to guide the direction of their research. This involvement can take place through the ‘Registers and Research Committee’ at the British Society for Rheumatology, where lay members and patient groups are...
Celebrate your registers! Collaboration: Collaboration with other biologics registers
The BSRBR-RA is one of four biologics registers run by the British Society for Rheumatology: BSRBR-RA (University of Manchester) UK JIA Biologics Register (University of Manchester) Psoriatic Arthritis Register (University of Aberdeen) Ankylosing spondylitis...
Celebrate your registers! Collaboration: Collaboration with international research groups
The BSRBR-RA is fortunate to be able to collaborate with numerous different research groups both across the UK and internationally. As part of the JAK-pot collaboration, 19 registers internationally – including the British Society for Rheumatology Biologics Register...
Celebrate your registers! Influence: Influencing clinical guidelines
Data from the BSRBR-RA study has influenced clinical guidelines.
Celebrate your registers! Impact: Long-term outcome data
The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BSRBR-RA) study has been central in understanding the long-term safety and effectiveness of biologic, biosimilar and JAKi therapies for rheumatoid arthritis (RA). Over the past two...
Join us at the BSR Annual Conference, 28-30 April 2025!
#BSR25 We are thrilled that we will be at the BSR’s Annual Conference next month. This conference offers a wide variety of talks across all aspects of rheumatology and rheumatology research. We are pleased that we will be attending and have the opportunity to meet...
Contact Us
+44 (0) 161 306 6000
Recent Comments